development is critical for formation of the semilunar valves. Fibulin-1 (Fbln1) is an extracellular matrix protein that is present at several sites of EMT, including the OFT (i.e., E9.5-10.5). The aim of this study was to determine the role of Fbln1 in EMT during the earliest events of OFT development. Examination of proximal OFT cushions in Fbln1 null embryos detected hypercellularity at both E9.5 (93% increase; p = 0.002) and E10.5 (43% increase; p = 0.01) as compared to wild type, suggesting that Fbln1 normally suppresses OFT endocardial cushion EMT. This was supported by studies of proximal OFT cushion explants, which showed that explants from Fbln1 null embryos displayed a 58% increase in cells migrating from the explants as compared to wild type (p = 0.005). We next evaluated the effects of Fbln1 deficiency on the expression of factors that regulate proximal OFT EMT. At E9.5, Fbln1 null proximal OFT endocardium and EMT-derived mesenchyme showed increased TGFβ2 (58% increase; p = 0.01) and increased Snail1-positive nuclei (27% increase; p = 0.0003). Histological examination of OFT cushions in Fbln1 null embryos (E9.5) also detected cells present in the cushion that were determined to be erythrocytes based on round morphology, autofluorescence, and positive staining for hemoglobin. Erythrocytes were also detected in Fbln1 null OFT cushions at E10.5. Together, the findings indicate that Fbln1 normally suppresses proximal OFT EMT preventing proximal cushion hypercellularity and blood cell accumulation.
Introduction
Formation of the semilunar valves begins in the mouse between embryonic days (E) E8.5 and E9.0 when the primary myocardium secretes a hyaluronan-rich extracellular matrix (ECM) resulting in opposing swellings that form the proximal and distal OFT endocardial cushions (Butcher and Markwald, 2007) . Subsequently, at approximately E10.5, a subset of endocardial cells within the proximal OFT undergo an endothelial to mesenchymal transformation (EMT) in response to regionspecific myocardial and endocardial signals exchanged across Abbreviations: OFT, outflow tract; AV, atrioventricular; EC, endocardial cushions; EMT, endothelial to mesenchymal transition; SMA, smooth muscle actin; TGF, transforming growth factor; NCC, neural crest cellsthis specialized ECM (Garside et al., 2012) . The transformed endocardial cells invade this ECM until around E11.5 after which EMT ends (Combs and Yutzey, 2009) . By E11.5, a second population of mesenchymal cells, the cardiac neural crest (NCC), infiltrate the distal OFT cushions to form the aorticopulmonary septum (Waldo et al., 1998) . Fate mapping studies suggest that the neural crest and the EMT-derived cells remain as separate populations and that the interaction between these two population promotes the positioning and patterning of the semilunar valves within the OFT (Phillips et al., 2013; Wu et al., 2011) . Ultimately, extensive growth and remodeling of the OFT cushions are required to form the final structured semilunar valve leaflets of the aorta and pulmonary artery (Barnett and Desgrosellier, 2003; Combs and Yutzey, 2009; Garside et al., 2012; Sizarov et al., 2012) .
The essential role of the ECM in promoting proximal OFT EMT is evident in embryos deficient in hyaluronan synthase-2 (Has-2) (Camenisch et al., 2000) or versican, which die around E10.5 and display hypoplastic atrioventricular (AV) and OFT endocardial cushions (Mjaatvedt et al., 1998) . Further analysis showed that hyaluronan (produced by Has-2) was required for ErbB receptor activation in order to induce EMT (Camenisch et al., 2002) . Although soluble growth factors (Bai et al., 2013; Dor et al., 2001; Garside et al., 2012; Sakabe et al., 2012) involved in OFT endocardial cushion EMT have been extensively studied, our understanding of how ECM proteins present in the proximal cushion potentiate these signals is limited.
Fibulin-1 (Fbln1) is an ECM protein present in the OFT cushion of both chick (Bouchey et al., 1996) and mouse (Cooley et al., 2008) during cardiac development. Studies using chick cushion explants have showed that Fbln1 suppresses fibronectin-mediated cell migration (Twal et al., 2001) , suggesting that Fbln1 may have an inhibitory role on cardiac cushion EMT. To evaluate the role of Fbln1 in proximal OFT EMT, we examined E9.5-E10.5 wild type and Fbln1 deficient embryos. Here we report a novel role for Fbln1 as a negative modulator of OFT EMT that represses TGFβ2 and Snail1 levels during cardiac semilunar valve morphogenesis.
2.
Materials and methods
Fbln1 deficient mice
This study employed a Fbln1 gene trap mutant that has previously been reported (Cooley et al., 2008) . All animal procedures were approved by the MUSC Institutional Animal Care and Use Committee and complied with federal and institutional guidelines.
Reagents used in immunohistochemistry
Primary antibodies used in this study were rabbit antiFbln1 (Argraves et al., 1990) , mouse anti-α-smooth muscle actin (αSMA) (Sigma Chemical Corp, St. Louis, MO), mouse antitransforming growth factor-β2 (Abcam, Cambridge, MA), goat anti-Snail1 (Abcam), rabbit anti-phospho-histone H3 (PHH3) (Millipore, Billerica, MA), and goat anti-VE-Cadherin (Santa Cruz Biotechnology, Dallas, TX). The primary antibodies were detected with the following secondary antibodies: Cy5-labeled donkey anti-rabbit IgG (Jackson Immunoresearch Laboratories), Cy5-labeled donkey anti-mouse IgG (Jackson Immunoresearch Laboratories), Alexa Fluor 568-labeled goat anti-rabbit IgG (Life Technologies, Carlsbad, CA), Alexa Fluor 488-labeled donkey anti-goat IgG (Life Technologies) and Alexa Fluor 488-labeled donkey anti-mouse IgG (Life Technologies).
Histology and immunohistochemistry
Wild type and Fbln1-deficient (E9.5-10.5) embryos were obtained from timed pregnant Fbln1 heterozygous matings. PCR was used to genotype embryonic tissue as described previously (Cooley et al., 2008) . E9.5 and E10.5 wild type and Fbln1 embryos were fixed in 4% paraformaldehyde, PBS. For Fbln1 staining, tissue was embedded in Optimal Cutting Temperature (OCT) compound and sectioned at 10 µm thickness. AntiFbln1 immunolabeling was performed on frozen tissue sections containing E9.5-E10.5 OFT regions from wild type and Fbln1 null embryos. For immunohistochemical detection of other proteins, fixed E9.5-E10.5 wild type and Fbln1 null embryos were embedded in paraffin, sectioned at 5 µm, and subjected to heatinduced antigen retrieval using a citric acid solution (H-3300, Vector Laboratories Burlingame, CA). Sections were treated with 1% BSA in PBS for 1 h followed by overnight incubation with primary antibodies for TGFβ2, Snail1, PHH3 or αSM actin. Bound primary antibodies were detected using fluorescently conjugated anti-mouse and anti-goat secondary antibodies. Nuclei were labeled with DRAQ5 (Cell Signaling, Danvers, MA) or Hoechst (Molecular Probes, Invitrogen Corp., Carlsbad, CA). Hematoxylin and eosin (H&E) staining was performed on paraffin sections using standard protocols. Fbln1 null OFT sections were used as negative controls for Fbln1 immunolabeling. Speciesappropriate normal IgGs were used in place of primary antibodies as negative controls for TGFβ2 and Snail1 immunolabeling.
Proliferation and apoptosis assays
The percentage of PHH3 positive cells in proximal OFT (E9.5 and E10.5) was calculated by counting the number of anti-PHH3 positive cells relative to the total number of nuclei using the Adobe Photoshop Count tool. For apoptosis analysis, TdTmediated dUTP Nick-End (TUNEL) assay was performed on paraffin sections (E10.5) using the Apo Tag system (Millipore) as per manufacturer's instructions.
2.5.
Morphometric analysis 3D reconstructions of proximal OFT cushions (E9.5) were generated using AMIRA. The anatomical dogleg bend at E9.5 was used as a boundary between the distal and proximal OFT cushions (Anderson et al., 2003) . ImageJ software (NIH) was used to perform area measurements. Volumetric measurements were calculated using the voxel size and the tissue thickness. Total cell counts (i.e., endothelial cells, mesenchymal and blood cells) were tabulated using the Adobe Photoshop counting tool. Endothelial cells were defined by positive staining for VE-Cadherin, which is a marker of endothelial cells. Erythrocytes were identified by Giemsa staining, distinct rounded morphology and/or autofluorescence in immunolabeling experiments. Cells in the cardiac jelly that showed rounded, spindle-shaped migratory morphology and the absence of a flattened endothelial morphology were defined as mesenchymal cells.
2.6.
AMIRA 3D reconstruction of protein distributions in the OFT cushion AMIRA (Visage Imaging, Andover, MA) was used to generate three-dimensional (3D) images of Fbln1 (E9.5 and E10.5) and TGFβ2 (E9.5) protein distribution. Quantification of TGFβ2 positive tissue was performed by summing the positive pixels (i.e., Cy5-labeled donkey anti-mouse detection of anti-TGFβ2 IgG) in a series of voxels in a stack from each OFT tissue (i.e., 5 µm sections of OFT cushions for anti-TGFβ2). Immunostaining conditions for wild type and Fbln1 null sections were performed under identical conditions; images were acquired by confocal microscopy using the same laser and gain settings.
2.7.
Benzidine staining
Paraffin sections of OFT regions from wild type and Fbln1 null embryos were deparaffinized in xylenes and rehydrated through an ethanol gradient. Sections were then washed in PBS for 5 min and stained with 3′3-diaminobenzidine reagent (Sigma-Aldrich) for 1 h at RT in accordance with the manufacturer's recommendations (Lu et al., 2008) . Slides were subsequently counterstained with eosin. Hemoglobin-containing cells (e.g., erythrocytes) were detected based on their brown staining.
Generation of Fbln1-depleted serum
An anti-Fbln1 IgG column was generated by coupling the monoclonal antibody 3A11 to Sepharose (Tran et al., 1997) . Fbln1 was depleted from Fetal Bovine Serum (FBS) by passing the serum over the monoclonal anti-Fbln1 3A11 IgG Sepharose column six times. Depletion of Fbln1 protein was verified by ELISA or immunoblotting.
2.9.
OFT cushion explant EMT assay OFT regions were dissected out of wild type and Fbln1 null hearts from E10.5 embryos (Bernanke and Markwald, 1982; Sugi et al., 2004) . The proximal OFT regions (Wu et al., 2011) were cut longitudinally and the endocardial side placed on a collagen gel (i.e., rat-tail type I collagen, 1 mg/ml,) equilibrated with OptiMEM (Invitrogen) medium supplemented with Fbln1-depleted fetal bovine serum (1% heat-inactivated), 1% ITS and 1% penicillin/streptomycin. Following 2 h of incubation at 37°C, additional medium was added and collagen gels were incubated for 48 h. EMT was assessed at 48 h using Hoffman optics on an inverted Leica microscope to count the number of cells that migrated from the explants into the collagen gels.
Statistical analysis
Fisher's exact test and Student's t-test (unpaired, two tailed variants) were used to determine the statistical significance of experimental results using Prism version 6.01 software (GraphPad, La Jolla, CA). Differences were considered significant at p < 0.05.
Results

3.1.
Fbln1 is expressed by the proximal and distal OFT cushions at E9.5 and E10.5
Immunolabeling of E9.5 wild type OFT sections ( Fig. 1A and B) showed that Fbln1 was detected in the ECM adjacent to the endothelium of the proximal and distal OFT cushions ( Fig. 1A and B). Similarly, at E10.5 Fbln1 was detected in the ECM adjacent to the endothelium and also around the EMT-derived mesenchymal cells ( Fig. 1D and E) of the OFT.
To further evaluate the spatiotemporal pattern of Fbln1, we generated three-dimensional (3D) reconstructions of E9.5 and E10.5 OFT cushion regions using AMIRA ( Fig. 1C and F) . In both reconstructions, Hoechst-stained cells (blue) marked the endocardial cells and the EMT-derived mesenchymal cells adjacent to the OFT lumen. Fbln1 expression (red) was evident in cellular cushion regions that are adjacent to the lumen ( Fig. 1C and F). Analysis of the 3D renderings showed that Fbln1 was deposited in the ECM of the distal and proximal OFT regions at both E9.5 and E10.5.
3.2.
Fbln1 deficiency results in hypercellular OFT cushions at E9.5
EMT initiates in the mouse OFT at approximately E10.5 (Garside et al., 2012) . As expected, examination of wild type embryos showed that very few cells were present in the OFT cushions at E9.5 ( Fig. 2A) . By contrast, analysis of Fbln1-deficient embryos revealed an abundance of cells present in the proximal OFT cushions at E9.5 (Fig. 2B ). Many of these cells had the characteristics of mesenchyme, i.e., a rounded, spindleshaped migratory morphology. Interestingly, other cells present in the cushions were distinctly round, stained intensely red by H&E (and blue by Giemsa, Supplemental Fig. S1 ) and generally appeared to be erythrocytes (Fig. 2D ). Benzidine staining was performed to determine whether these cells were positive for hemoglobin. As shown in Fig. 2E , cells inside the OFT lumen of wild type embryos stained positively for hemoglobin, as would be expected for erythrocytes circulating at this stage. Analysis of the Fbln-1 null OFT samples revealed that the presumptive erythrocytes present within the cushions also stained positively for hemoglobin (Fig. 2F) . Notably, the erythrocytes in the lumen and the cushions were nucleated, which is characteristic of primitive erythrocytes that are present at this developmental stage. Thus, in addition to the increase in mesenchymal cells, there was accumulation of at least one type of blood cell in the proximal OFT cushions in Fbln1 nulls at E9.5.
Quantitative analysis of cell types present in the proximal OFT at E9.5 showed that there was no difference in the number of endothelial cells between wild type and Fbln1 deficient embryos (Table 1) . However, as shown in Fig. 2G , the total number of mesenchymal cells was increased in the proximal OFT of Fbln1 nulls compared to wild types (354% increase, p = 0.0002). Additionally, quantitative analysis of erythrocyte numbers revealed that there was a complete absence of these cells in the cushion of wild type samples while there was a mean of approximately 0.48 blood cells/mm (Garside et al., 2012) in Fbln1 null proximal OFT cushions at this stage ( Fig. 2H ; Table 1 ) (n = 4 for each genotype).
The increase in mesenchymal cell number suggested the possibility that cell proliferation rates were increased in Fbln1 null embryos. PHH3 immunolabeling was performed to quantify cell proliferation rates in proximal OFT of E9.5 wild type and Fbln1 null embryos. However, analysis of PHH3 positive cells detected no apparent difference in proliferation of mesenchymal and endothelial cells between wild type and Fbln1 null E9.5 OFT cushions (Table 1) .
To visualize and compare endothelial, mesenchymal, and erythrocyte content in the entire E9.5 proximal OFT cushion, AMIRA 3D reconstructions were generated for wild type and Fbln1 null embryos. Reconstructions of the wild type cushion revealed the endothelial cell-containing region (purple), but also showed the near absence of mesenchymal cells (blue) and the complete absence of blood cells (red) (Fig. 2I ). These patterns were starkly contrasted in the Fbln1 null reconstructions (Fig. 2J) , which showed abundant mesenchymal and erythrocytecontaining regions throughout the length of the proximal OFT. Taken together, these results indicate that Fbln1 normally limits EMT in the proximal OFT at E9.5 and prevents accumulation of blood cells.
3.3.
Fbln1 deficiency results in hypercellular OFT cushions at E10.5
Analysis of OFT cushions at E10.5 again revealed differences in cellular content between wild type and Fbln1 null embryos. Mesenchymal cell numbers in the proximal OFT cushions of Fbln1 nulls were increased by approximately 50% compared to wild type (p = 0.06; n = 5) ( Fig. 3A ; Table 2 ). By contrast, distal OFT cushions at this stage showed no significant difference in the number of mesenchymal cells between Fbln1 null and wild type samples (p = 0.87; n = 5) (Fig. 3B) . Additionally, there was no difference in levels of apoptosis (p = 0.53; n = 5) or proliferation (p = 0.49; n = 5) in the distal OFT at this stage ( Fig. 3C-E ). Erythrocytes were detected in both the proximal (Table 2 ) and distal OFT cushions of Fbln1 nulls at E10.5 while none were detected in either cushions in wild types (Supplemental Fig. S3 ).The number of erythrocytes in the proximal OFT cushions of Fbln1 nulls was notably higher than in the distal cushions.Taken together, these findings indicate that Fbln1 limits EMT in the proximal OFT at E10.5 and prevents blood cells from accumulating in both the proximal and distal cushions. 
3.4.
Fbln1 deficiency results in increased EMT in OFT cushion explant cultures at E10.5
To assess the effect of Fbln1 deficiency on OFT EMT, explant culture assays were performed on OFT samples taken from E10.5 wild type and Fbln1 null embryos. Micrographs of explants cultured for 48 h revealed an apparent increase in cell outgrowth in the Fbln1 null explant compared to wild type ( Fig. 4A and B) . Quantitative analysis confirmed that Fbln1 null OFT cushion explants showed a 58% increase in outgrowth cells compared to wild type samples (p = 0.005; n = 4) (Fig. 4) . These findings support the conclusion that Fbln1 normally suppresses EMT in the proximal OFT.
3.5.
Fbln1 deficiency results in increased TGFβ2 and Snail1 levels in OFT cushions at E9.5
To investigate potential linkages between Fbln1 and the increased EMT observed in Fbln1 null embryos, we examined the expression of TGFβ2 and its transcriptional target Snail1, which together represent an established positive regulator of EMT (Niessen et al., 2008) . Immunolabeling of E9.5 OFT cushions showed that there was a 58% increase in TGFβ2 protein in the proximal OFT of Fbln1 nulls compared to wild type (p = 0.01, n = 3) (Fig. 5A-C) . The TGFβ2-induced gene, Snail1, also showed a 27% increase in immunoreactivity in the proximal OFT of Fbln1 null cushions at E9.5 (p = 0.0003, n = 4) ( Fig. 5D-F) . These findings suggest that Fbln1 normally suppresses proximal OFT EMT through a mechanism(s) that may involve negative feedback on the TGF β2/Snail1 pathway, thereby preventing endocardial cushion hypercellularity.
Discussion
The mouse heart at E8.5-E9.0 is a simple linear tube that consists of an endothelium surrounded by ECM and several layers of myocardium. The primitive heart tube undergoes rightward rotation to form a single atrium and ventricle along with two areas of constriction: 1) the atrioventricular canal (AVC) located between the atrium and the ventricle, and 2) the OFT located between the ventricle and the aortic sac. In response to myocardial-derived Bmp, these two regions, AVC and OFT, express hyaluronan resulting in localized swellings of ECM to form the primitive acelluar AV and OFT endocardial cushions (Bai et the semilunar valves requires that the acellular ECM be populated by mesenchymal cells derived from several sources, including EMT, neural crest and secondary heart field (Combs and Yutzey, 2009) . Collectively the OFT cushions are comprised of distal cushions, proximal cushions and a pair of intercalated cushions, and give rise to the transient septum, arterial walls and semilunar valve leaflets. In the post-natal heart, mesenchymal cells originating from NCC are present in the arterial walls and in the semilunar valve leaflets (Jiang et al., 2000; Phillips et al., 2013) while cells originating from proximal cushion EMT reside almost exclusively in the fully formed semilunar valve cusps (de Lange et al., 2004; Phillips et al., 2013) . There is some indication that semilunar valve leaflets derived from the intercalated cushions, that form later in development, have reduced numbers of neural crest derived cells (Phillips et al., 2013) . The contribution of neural crest-and EMTderived cells to the post-natal semilunar valves has not been studied extensively.
Although several ECM proteins are known to influence EMT, the majority of these proteins promote mesenchymal cell invasion of the endocardial cushions (Camenisch et al., 2000; Garside et al., 2012; Mjaatvedt et al., 1998; Patra et al., 2011) . Relatively few proteins are known to negatively regulate OFT EMT and cushion invasion (Dor et al., 2001) . Here, our results demonstrate that the ECM protein Fbln1 is a negative regulator of cardiac OFT EMT. First, Fbln1 deficiency resulted in increased EMT that led to a hypercellular proximal OFT cushion phenotype at E9.5-E10.5. Second, cushion explant cultures prepared from E10.5 proximal OFTs showed that Fbln1 null samples had a 58% increase in the number of migratory cells. Together these findings indicate that Fbln1 normally suppresses cardiac OFT EMT at E9.5-E10.5. Furthermore, these findings are consistent with prior studies showing that exogenous Fbln1 inhibited invasion of endocardial cushion mesenchymal cells migrating from cultured embryonic heart explants (Twal et al., 2001) .
Our results also indicate that Fbln1 is a suppressor of TGFβ2 and Snail1 production during proximal OFT development. We speculate that the elevated TGFβ2 observed in Fbln1 nulls causes an increase in Snail1 expression and a subsequent increase in EMT in the proximal OFT. This would be consistent with previous studies showing that TGFβ2 directly induces transcription of Snail1, which is implicated in the initiation of EMT (Niessen et al., 2008; Timmerman et al., 2004) , and that increased TGFβ2 expression causes increased EMT (Shirai et al., 2009 ) and a hypercellular cushion phenotype (Sakabe et al., 2012; Shirai et al., 2009) . Furthermore, the induction of Snail1 expression by TGFβ2 treatment has been shown to rescue EMT defects in the developing heart (Niessen et al., 2008) .
While the underlying mechanism by which Fbln1 represses the TGFβ2/Snail1 pathway remains to be studied, one possible mechanism would be that Fbln1 influences the release of TGFβ2 from the ECM. The secreted ECM protein Emilin-1 has been shown to bind to the TGFβ precursor, proTGFβ, and prevent its maturation and bioavailability (Zacchigna et al., 2006) . Taking into account that TGFβ2 levels are increased in the absence of Fbln1, it is possible that Fbln1 normally acts as a negative regulator of TGFβ2 by directly binding to either the large latent complex or the small latent complex, making it less accessible to proteolytic cleavage by matrix metalloproteinases (MMPs), thereby limiting its release from the ECM and reducing bioavailability of TGFβ2 during OFT cushion morphogenesis.
Findings from this study also revealed that loss of Fbln1 resulted in the accumulation of cells in the proximal OFT cushions at E9.5 and E10.5 that were judged to be erythrocytes. This conclusion was based on round morphology of the cells, intense staining with Giemsa, autofluorescence in immunological staining, and expression of hemoglobin. Hematopoiesis begins in PHH3 analysis was performed on 15 sections from 2 wild type and 15 sections from 2 Fbln1 null embryos. e,f n = 4. g Percent change calculated as change in Fbln1 null relative to wild type. h P value was calculated using Student's t-test. a,d P value was calculated using Fisher's exact test.
the mouse in the yolk sac at approximately E7, and primitive erythrocytes enter the blood stream when circulation is established at approximately E8.5 (Palis et al., 1999) . At the stages examined in this study, erythrocytes constitute the majority of the circulating blood cell population (Hirschi, 2012; Palis et al., 1999; Silver and Palis, 1997) .
The mechanism by which erythrocytes accumulate in the OFT cushions has not been established. One possibility is that circulating cells enter the cushions from the OFT lumen. During EMT, the endocardium is permeable as the endocardial cells lose their polarity and start migrating into the cushions (Garside et al., 2012; Lim and Thiery, 2012) . The loss of Fbln1, and the enhanced EMT that follows, may further destabilize the proximal OFT endothelial barrier at E9.5, allowing entry of circulating cells into the proximal OFT cushions. Such an explanation would account for the elevated number of erythrocytes in the proximal cushions, where EMT occurs, compared to the distal cushions, where the mesenchyme is populated primarily by migrating neural crest cells (Wu et al., 2011) . However, the fact that erythrocytes were also present in the distal OFT cushions would suggest that Fbln1 normally provides stabilization of the OFT endocardium irrespective of EMT. Previous studies have shown that mice deficient in Fbln1 display defects in the endothelial layer of some blood vessels that is characterized by dilation and rupture (Kostka et al., 2001) . Those findings support the possibility that endocardial barrier is compromised by the loss of Fbln1, and that erythrocytes in circulating blood enter the cushions due to endocardial barrier disruption.
A second possibility is that in the absence of Fbln1, erythrocytes originate in situ in the OFT cushions. OFT endocardium (Nakano et al., 2013; Van Handel et al., 2012) has been shown to have hemogenic potential that begins at around E9.5. It is possible that Fbln1 supports this specification in a way that maintains production of hematopoietic cells on the luminal side of the endocardium. Thus, in the absence of Fbln1, the hemogenic OFT endocardium may generate erythrocytes on the inner (i.e, cardiac jelly) side of the endocardium. Studies of the effect of T cell acute lymphocytic leukemia 1 deficiency (Scl/tal1) in cardiac cushions have shown that such a misspecification of endocardium can occur (Nakano et al., 2013) .
Here we have shown that the ECM protein Fbln1 is important for mouse OFT morphogenesis. Fbln1 is present in proximal and distal OFT cushions, and our results indicate that Fbln1 normally suppresses EMT in the proximal OFT cushion and prevents hypercellularity, including the accumulation of erythrocytes. The loss of Fbln1 was linked to the upregulation of both TGFβ2 and Snail1, both established stimulators of EMT. Future experiments are expected to elucidate how Fbln1 influences the TGFβ2/Snail1 pathway and how Fbln1 stabilizes the structure and/or specification of the OFT endocardium. 
